Horizon Pharma raises bid for Depomed to $33 per share
0
Drugmaker Horizon Pharma PLC is boosting its offer for Depomed to $33 per share.
Drugmaker Horizon Pharma PLC is boosting its offer for Depomed to $33 per share.